William J. Rutter is listed as a director on 2 SEC Form D filings by 2 issuers between Sep 2020 and Aug 2022: Bluejay Therapeutics, Inc. (San Mateo, CA — other technology — 2022; $182M reported sold to 19 investors) and ProLynx, Inc. (San Francisco, CA — biotechnology — 2020; $55K reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $182.1M sold in total.
Listed alongside Alon Lazarus (1 shared filing), Anurag Bagaria (1 shared filing), Dajun Yang (1 shared filing), Daniel Santi (1 shared filing), Keting Chu (1 shared filing) and 6 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around William. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 court cases matching the name, 5 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for William J. Rutter and found 4 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "William J. Rutter" (IN) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.